跳至主要内容
临床试验/NCT02776488
NCT02776488撤回2 期

Exogenous Sodium Lactate Infusion in Traumatic Brain Injury (ELI-TBI)

University of California, Los Angeles1 个研究点 分布在 1 个国家开始时间: 2020年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
撤回
试验地点
1
主要终点
Mortality within 30 days

研究概览

简要总结

Metabolic crisis is a state of energy insufficiency due to impaired mitochondrial function as indicated by cerebral microdialysis lactate/pyruvate ratio (LPR). We have performed preliminary mechanistic analysis of alternative fuels in humans and have demonstrated proof of concept that exogenous fuels alter brain metabolism. We will conduct a multicenter, adaptive design-based, proof of concept phase 2 safety study of candidate supplemental fuels in patients with severe traumatic brain injury to determine safety and efficacy.

详细描述

Metabolic crisis is a state of energy insufficiency due to impaired mitochondrial function as indicated by cerebral microdialysis lactate/pyruvate ratio (LPR). We have performed safety analysis of exogenous sodium lactate infusions in humans and have demonstrated proof of concept that these fuels alter brain metabolism. Animal TBI studies have demonstrated proof of concept for exogenous lactate and pyruvate. We will conduct a multicenter, adaptive design-based, proof of concept biomarker mechanistic safety study of exogenous sodium lactate. The preliminary goal is to determine if exogenous lactate infusion is safe and has a demonstrated effect on selected biomarkers.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients seen in the Medical Center Emergency Department
  • Adult patients transferred to the Neurocritical Intensive Care Unit with a physician's diagnosis of brain injury.

排除标准

  • Pregnancy at time of injury
  • History of diabetes mellitus
  • History of hemodynamic instability
  • Known terminal illness which alters brain functioning
  • Diagnosed AIDS progressed to AIDS dementia
  • Known history of chronic severe neurological disturbance
  • Severe retardation
  • Previous severe diminished mental capacity
  • No command of either English or Spanish
  • Arrest for a felony
  • Active neurologic condition such as stroke, recent TBI
  • metabolic disorder
  • preexisting hyperlactatemia
  • instability precluding experimental intervention

研究组 & 干预措施

ELI Arm

Experimental

Infusion of exogenous sodium lactate as supplemental fuel within 48 hours of TBI

干预措施: Sodium Lactate (Drug)

Placebo

Placebo Comparator

Placebo infusion of normal saline in Part 2 RCT

干预措施: Placebo (Drug)

结局指标

主要结局

Mortality within 30 days

时间窗: 30 days

Percentage mortality within 30 days

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Paul Vespa, MD

Professor

University of California, Los Angeles

研究点 (1)

Loading locations...

相似试验